-
Bristol Myers Squibb announced it has been recognized as One of America's Most JUST Companies. The ranking, presented by JUST Capital and CNBC, recognized BMS for its commitment to key social responsibilities, including employees, customers, communities, and environmental impact.
-
This week, BMS announced a 15-year virtual power purchase agreement (VPPA) with National Grid Renewables for 145 megawatts (MW) of solar at the Texas-based Blevins Project. Combined with the 15-year VPPA with EDP Renewables secured in 2022, this move puts BMS another step closer.
-
- Commitments demonstrate leadership in advancing health equity and workforce representation to better serve patients and communities
- $10 million in 2023 grant funding to 17 U.S. organizations focused on addressing social determinants of health
- Expanding aspirational workforce representation goals for those in senior leadership roles
-
Kareem Abdul-Jabbar is teaming up with Bristol Myers Squibb and Pfizer to raise awareness of atrial fibrillation (AFib) and its symptoms as part of the No Time to Wait campaign.
-
Hi, my name is Dana Walker. I’m the development program lead for genitourinary cancers here at Bristol Myers Squibb. I’m proud to lead a team of people continuing to develop treatments that help improve and extend the lives of patients dealing with genitourinary cancers.
-
A decade ago, the evolution of immuno-oncology transformed the landscape of therapy for patients with many cancers. Although individual immunotherapies have helped to improve outcomes for patients.
-
The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Award Program) established by the Bristol Myers Squibb Foundation (BMSF) announced that Amgen, a global biotechnology company, has committed to contribute $8 million over the next four years.
-
A handful of inspirational words from author Scott Stoll served as the rallying cry for more than 350 Bristol Myers Squibb employees representing 23 nations who successfully trained and participated in four regional bicycle rides collectively known as C2C4C.
-
The experience was “miraculous” for Asalia, and this story is one of countless from the annual walks that support the Leukemia and Lymphoma Society (LLS), with which Bristol Myers Squibb has had a long-standing partnership.
-
For too many years, cancer patients in Lesotho felt life-changing cancer treatment was out of reach. No oncology clinics existed in their landlocked country ringed by steep mountains and surrounded by South Africa.
-
Each November marks Lung Cancer Awareness Month in the United States. Lung cancer is the leading cause of cancer deaths in the country, taking more lives than breast, colon and prostate cancers combined.
-
Bristol Myers Squibb has a long-standing partnership with The Leukemia & Lymphoma Society (LLS) and has been the top biopharma fundraising team for Light The Night® for more than a decade.
-
64 physicians comprise Cohort II, bringing the total to 116 participants in the program’s second year
-
Inaugural “Humankind 100” ranking celebrates companies with purpose
Alphabet scores highest in this year’s ranking
-
The Bristol Myers Squibb Foundation (BMSF) announced that an additional 64 physicians have been selected to receive the Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA).
-
This year, in recognition of World Psoriasis Day on October 29, we’re focusing on the mental health challenges that people living with psoriatic disease face as a result of their illness.
-
Meet John Loveseth, the global lead for CLIMB (Cultivating Leadership in Millennials and Beyond), one of our eight People & Business Resource Groups (PBRGs) at Bristol Myers Squibb.
-
We encourage all colleagues to bring their authentic selves to work, and we believe diverse thinking and a collaborative culture can help spark innovation.
-
Voices From R Personal Experience Inspires the Development of New Medicines Thu, 10/13/2022 - 10:30 Subheader Culture of support fosters innovation Type of Content Blog Layout Media Gallery Body As a bench scientist, Matt Labrecque has a front-row seat to the discovery of new medicines. An innate passion for science and patients powers his work, but his inspiration to help patients goes beyond the professional. Matt is a Bristol Myers Squibb employee who lives with multiple sclerosis and clinica
-
Scientific and Hiking Adventures To Inspire the Next Generation of Researchers Wed, 10/05/2022 - 13:30 Type of Content Article Layout Featured Media Body When Tamica D’Souza applied for a research and development internship at Bristol Myers Squibb, she had no idea that a few months later she would be loading up a 30-pound backpack in preparation for a once-in-a-lifetime opportunity to take a multi-day hiking trip through the wilderness of the Sierra Nevada Mountains in California. A culmination
-
From Patient to Physician: Trading Places Mon, 09/26/2022 - 11:30 Subheader By Estelle Vester-Blokland, MD, Senior Vice President, Global Medical Affairs Type of Content Blog Layout Featured Media Body At Bristol Myers Squibb, Global Patient Week stands as a pinnacle of our year-round vision to transform patients’ lives through science, bringing together our more than 32,000 employees around the world to celebrate the individuals we work each day to serve. This year, in collaboration with the pa
-
Keep the Wheels Turning Tue, 09/20/2022 - 12:45 Subheader By Karin Shanahan, Executive Vice President, Global Product Development and Supply Type of Content Article Layout Featured Media Body At Bristol Myers Squibb, Global Patient Week stands as a pinnacle of our year-round vision to transform patients’ lives through science, bringing together our more than 32,000 employees around the world to celebrate the individuals we work each day to serve. This year, in collaboration with the patient advo
-
Exploring Pathways in Immune-Mediated Diseases To Advance Patient Care Wed, 09/14/2022 - 10:30 Type of Content Article Layout Featured Media Body Alyssa Johnsen, vice president and head of clinical development, Immunology and Fibrosis, shares her perspective on the great strides that have been made in the science of modulating the body’s immune response to treat disease. Alyssa started her career as a physician-scientist, where she was focused on understanding the pathophysiology of complex auto
-
Using the Power of Technology To Better Serve Our Patients Mon, 09/12/2022 - 14:15 Type of Content Blog Layout Featured Media Body By Greg Meyers At Bristol Myers Squibb, Global Patient Week stands as a pinnacle of our year-round vision to transform patients’ lives through science, bringing together our more than 32,000 employees around the world to celebrate the individuals we work each day to serve. This year, in partnership with the patient advocacy groups we partner with, we asked a few of o
-
Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research Wed, 09/07/2022 - 12:20 Subheader More than 126 employees to ride in the company’s annual Coast 2 Coast 4 Cancer ride through towns and cities between the Oregon Coast and the New Jersey shore Type of Content Press Release Layout Featured Media Body PRINCETON, N.J., September 7, 2022 /3BL Media/ - Bristol Myers Squibb employees will embark on a cross
-
Schneider Electric today announced that both Amgen and Bristol Myers Squibb have joined Energize – a program designed to increase access to renewable energy for pharmaceutical suppliers.
-
From Numbers to Knowledge: Unlocking the Predictive Power of Data To Accelerate Transformative Science This collaborative, integrated process can lead to: followed by seven points of progress"" typeof="foaf:Image" />Tue, 08/23/2022 - 11:00 Type of Content Article Layout Featured Media Body Scientists and experts at Bristol Myers Squibb are working to revolutionize the process of drug development with sophisticated scientific strategies driven by technology. Using computer science, advanced cl
-
Today's Cell Therapy Insights Shaping Tomorrow Thu, 08/04/2022 - 11:00 Subheader Bristol Myers Squibb leaders share the latest in the field Type of Content Article Layout Featured Media Body While cancer remains one of the greatest global health challenges, there have been unprecedented breakthroughs and innovations in cancer research in recent years, and more people are living longer with cancer than ever before. One innovation changing the way certain cancers can be treated and offering hope t
-
C2C4C: Back on the Road and Bigger Than Ever Mon, 08/01/2022 - 11:00 Subheader Rides have raised more than $12 million to help fund cancer research worldwide to date Type of Content Article Layout Featured Media Body This year, C2C4C is back and bigger than ever. Nearly a decade ago, the first Coast 2 Coast 4 Cancer cycling event began with 53 employees riding 3,000 miles across the U.S. to honor loved ones impacted by cancer by raising funds for cancer research. Now in 2022, there are more than
-
The Future of Diversity in Clinical Trials Thu, 07/21/2022 - 11:30 Subheader Meet some of the first cohort of diverse medical students dedicated to improving health equity who have been chosen to participate in the Robert A. Winn Clinical Investigator Pathway Program. Type of Content Article Layout Featured Media Body When he was 11 years old, Cesar Ramirez contracted a joint infection that spread throughout his body. During a three-month stay in the hospital, his two physicians became not only
-
Pioneering Paths Forward in Immunology Tue, 07/12/2022 - 12:45 Type of Content Article Layout Featured Media Body Q: What approach is Bristol Myers Squibb taking to develop new therapies for immune-mediated diseases? Sadeh: At Bristol Myers Squibb, we are building a portfolio grounded in pathbreaking science that addresses unmet needs for people living with immune-mediated diseases in rheumatology, gastroenterology, dermatology and neurology. Our approach starts with a deep understanding of the
-
Juneteenth: Remembering the Past, Reimagining the Future Wed, 06/22/2022 - 11:00 Subheader Bristol Myers Squibb encourages its workforce to pause, reflect and participate in a culture of inclusion in observance of Juneteenth Type of Content Article Layout Featured Media Body On June 20, Bristol Myers Squibb has reserved the day to honor Juneteenth, to allow the workforce to pause, reflect and play a part in a culture of inclusion. “Recognizing Juneteenth as a company holiday demonstrates and amp
-
Kellie Calderon, MD, executive medical director at Bristol Myers Squibb, has built her career in both clinical practice as well as in the pharmaceutical industry.
-
What is lupus and how does it impact patients’ lives?
-
SOURCE: Bristol Myers Squibb Company DESCRIPTION:Subhashish Banerjee, MD, vice president disease area head, Rheumatology and Dermatology at Bristol Myers Squibb, shares how the company is leveraging a pathways-based approach to advance research and ultimately elevate care for patients in need of new treatment options in systemic lupus erythematosus (SLE), also known as lupus. Q: What is lupus and how does it impact patients’ lives? A: Systemic lupus erythematosus (SLE), or lupus, is a chronic imm
-
SCFG was founded in 1994 to foster excitement, confidence and literacy in STEM for girls and gender-expansive youth from historically underrepresented communities with free, experiential community-based programs.
-
May is Asian American Pacific Islander heritage month, celebrating the fastest-growing racial group in the United States.
-
EDP Renewables SA (EDPR), through its fully owned subsidiary EDP Renewables North America LLC (EDPR NA), and Bristol Myers Squibb (NYSE: BMY) have executed a 15-year power purchase agreement (PPA) for 60 megawatts (MW) at the 240-MW Cattlemen Solar Park in Milam County, located in central Texas.
-
Abderrahim Oukessou, MD, our vice president and Thoracic Cancers Development Lead, sat down with Adam Schoenfeld, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, to discuss how the landscape of lung cancer research has transformed in recent years.
-
In his 15 years as a lung cancer specialist, Professor Nicolas Girard, MD, PhD, of the Curie-Montsouris Thorax Institute has seen – and helped advance – dramatic changes in how patients with this disease are treated.
-
Hypertrophic cardiomyopathy (HCM) is a chronic, inheritable disease where there is excessive thickening of the heart muscle.
-
As a leading global healthcare provider, Bristol Myers Squibb recognizes that a healthy planet underpins the company’s vision to transform patients’ lives through science.
-
This Earth Month, learn how a Bristol Myers Squibb facility in the UK has transformed its reputation SOURCE: Bristol Myers Squibb Company DESCRIPTION:As a leading global healthcare provider, Bristol Myers Squibb recognizes that a healthy planet underpins the company’s vision to transform patients’ lives through science. Bristol Myers Squibb detailed its specific environmental sustainability goals in 2020; around the world, company teams have been working to reduce greenhouse gas emissions, increa
-
When a new “rash” appears on the skin, many people may not associate it with psoriasis.
-
In 2019, Mianna Burnett, manager, Business Operations, Bristol Myers Squibb, and her husband were rocketed into the most trying time in their lives — her husband was diagnosed with cancer.
-
Health disparities have negatively impacted many different groups of patients for decades, and the LGBTQ+ community is no exception.
-
The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced a new name for the $100 million, five-year initiative launched in 2020 to increase diversity in clinical trials: The Robert A. Winn Diversity in Clinical Trials Award Program.
-
Covid restrictions are being relaxed around the world. Masks are slowing coming off and face to face interactions seem real again.
-
Inspiration can come in many forms.
-
The Bristol Myers Squibb Network of Women (B-NOW) drives business performance by ensuring that all women at Bristol Myers Squibb have equal opportunities to develop, advance, and be retained globally.